CH311610A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).Info
- Publication number
- CH311610A CH311610A CH311610DA CH311610A CH 311610 A CH311610 A CH 311610A CH 311610D A CH311610D A CH 311610DA CH 311610 A CH311610 A CH 311610A
- Authority
- CH
- Switzerland
- Prior art keywords
- anilide
- methyl
- isopropylamine
- chloro
- fatty acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6-methyl-anilids).
Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-anilids), welches dadllreh gekennzeich- net ist, da¯ man eine Verbindung der Formel
EMI1.1
in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Best bedeutet, mit Isopropylamin umsetzt.
Der Rest X kann in einem Ha. logenatom oder einem sonstigen f r den Austauseh gegen den basischen Rest geeigneten reaktionsfähi- gen Substituenten, wie z. B. einer Alkylsul- fonyloxy-oder Arylsulfonyloxygruppe, bestehen. Der Austausch der Gruppe X gegen den Isopropylaminrest erfolgt z. B. durch einfaches Erwärmen mit Isopropylamin gege benenfalls in Gegenwart eines basisch reagierenden Kondensationsmittels oder von Isopro pylamin im Überschuss. Das Isopropyl-amino- acet- (2-chlor-6-methyl-anilid) ist ein farbloses, unter 0, 01 mm Hg bei 132 siedendes Íl.
Das Hydroehlorid der Base schmilzt bei 178-180 .
Das neue Anilid salol als Lokalanästhetikum und als Zwischenprodukt zur Herstellung wei terer Derivate Verwendung finden.
Beispiel :
36 Gewichtsteile Chloracet- (2-chlor-6-me- thyl-anilid) (gewonnen durch Umsetzen von 2 Chlor-6-methyl-anilin mit Chloraeetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 200 Gewichtsteilen wϯriger 60 /oiger Isopropylaminlösung suspen- diert. Die Temperatur steigt dabei leicht an, und ein grosser Teil des Reaktionsgemisches geht in L¯sung. Nun wird während 4 Stunden bei Zimmertemperatur gerührt, und dann einige Stunden in geschlossenem Gefäss bei 100-120 . Eine Probe mit Wasser und nachfolgend mit verdünnter SalzsÏure versetzt ergibt wieder Losung des ausgefallenen Niederschlages.
Mit Wasserdampf wird hierauf der Alkohol und das übersehüssige Isopropylamin abgeblasen und nach dem Erkalten das zu- rückbleibende Ol in ather aufgenommen. Nach dem Trocknen der ätherischen Lösung und d Verjagen des Losungsmittels verbleibt ein öl, das durch Vakuumdestillation gereinigt wird.
Man erhält 35 Gewiehtsteile reines Isopropyl aminoa. cet- (2-chlor-6-methyl-anilid). Die Umsetzung mit Isopropylamin kann auch in Ben- zol stattfinden.
PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten FettsÏure- (2-halogen-6methyl-anilids), dadurch gekennzeichnet, daR man eine Verbindung der Formel
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
The subject of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl-anilide), which is marked as a compound of the formula
EMI1.1
in which X denotes a reactive Best which is split off during the reaction, reacts with isopropylamine.
The rest of X can be in a Ha. logenatom or any other reactive substituents suitable for exchange with the basic radical, such as B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the isopropylamine residue takes place, for. B. by simply heating with isopropylamine, if necessary, in the presence of a basic condensing agent or isopropylamine in excess. Isopropyl-amino-acet- (2-chloro-6-methyl-anilide) is a colorless oil that boils below 0.01 mm Hg at 132.
The hydrochloride of the base melts at 178-180.
The new anilide salol can be used as a local anesthetic and as an intermediate product for the production of further derivatives.
Example:
36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroethyl chloride in the presence of sodium acetate, melting point 140 to 141) are aqueous in 200 parts by weight 60% isopropylamine solution suspended. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature, and then for a few hours in a closed vessel at 100-120. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate.
The alcohol and the excess isopropylamine are then blown off with steam and, after cooling, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation.
35 parts by weight of pure isopropyl aminoa are obtained. cet- (2-chloro-6-methyl-anilide). The reaction with isopropylamine can also take place in benzene.
PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halogen-6methyl-anilide), characterized in that a compound of the formula
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH311610T | 1952-02-25 | ||
CH307799T | 1952-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH311610A true CH311610A (en) | 1955-11-30 |
Family
ID=25735343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH311610D CH311610A (en) | 1952-02-25 | 1952-02-25 | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH311610A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
-
1952
- 1952-02-25 CH CH311610D patent/CH311610A/en unknown
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11643404B2 (en) | 2019-03-11 | 2023-05-09 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US12195428B2 (en) | 2019-03-11 | 2025-01-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11603355B2 (en) | 2019-03-11 | 2023-03-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11512058B2 (en) | 2019-03-11 | 2022-11-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11696912B2 (en) | 2019-11-06 | 2023-07-11 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH311610A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311606A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311613A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311609A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311608A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311612A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311614A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311607A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311615A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311604A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311629A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311605A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311603A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311621A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH312572A (en) | Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide | |
CH311630A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311644A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311627A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311639A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311642A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311632A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311624A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311631A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH328671A (en) | Process for the production of a new basic substituted fatty acid-2-halogen-6-methyl-anilide | |
CH311619A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |